Professor Tamar Safra is an oncologist with more than 25 years of experience, a specialist in radiotherapy, head of the oncogynecological department of the Sourasky State Medical Center (Ichilov). She also runs a private practice at the Assuta Clinic.

The doctor treats ovarian cancer with the use of targeted drugs – PARP inhibitors. Performs molecular genetic testing of tumors of the female genital area and, based on their results, selects an individual therapy protocol for each patient.

Works as part of a multidisciplinary team of specialists, which includes radiologists, oncosurgeons, reproductive specialists. If possible, she treats malignant tumors of the breast while preserving the reproductive function of a woman.

• Leiomyosarcoma of the uterus;
• breast cancer;
• bladder cancer;
• Paget’s cancer;
• spleen cancer;
• cervical cancer;
• ovarian cancer;
• triple negative breast cancer;
• endometrial cancer.

• Hebrew University in Jerusalem (Israel), graduated from the Faculty of Medicine, Doctor of Medical Sciences;
• Tel Aviv University, studied oncology at the Faculty of Medicine;
• Hadassah Medical Center (Jerusalem, Israel), residency in the Department of Oncology;
• Norris Cancer Center (University of Southern California, Los Angeles, USA), internship in gynecological oncology.

The professor is engaged in the study and therapy of breast and ovarian cancer in women with mutations in the BRCA1 and BRCA2 genes. Carries out the development and implementation of innovative biological preparations in oncogynecology.

She takes part in international studies to increase the effectiveness of chemotherapy and reduce its side effects.

She is the author of over 70 scientific papers published in international medical buildings.

• American Association of Clinical Oncology;
• Breast Cancer Treatment Group;
• European Association of Gynecological Oncology;
• Israeli Association of Clinical Oncology and Radiation Therapy;
• Israeli Association of Gynecological Oncology;
• Israeli Medical Association.